Evidence map›Paper›PMID 26121587›Full record

ReviewParasite immunology2015

Does EBV alter the pathogenesis of malaria?

C G Matar, N T Jacobs, S H Speck, T J Lamb, A M Moormann

Open access · greenAbstract readReview
In one paragraph

Review in Parasite immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

C G MatarDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
N T JacobsDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
S H SpeckDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
T J LambDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
A M MoormannProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Emory University · USUniversity of Massachusetts Chan Medical School · US

Funding

Function of the Gamma HV68 M2 AntigenR01AI058057 · NIAID · EMORY UNIVERSITY · PI SPECK, SAMUEL H · 2004 to 2016
$4.5M
Suppression of anti-malarial humoral immune responses by gamaherpesvirusesR01AI123425 · NIAID · UNIVERSITY OF UTAH · PI LAMB, TRACEY JANE · 2017 to 2021
$1.9M
NIAID NIH HHS R01 AI058057NIAID NIH HHS R01 AI123425
6 · The paper itself

Abstract

Plasmodium falciparum infections have been implicated in immune deficiencies resulting in ineffective control of Epstein-Barr virus, thereby increasing the risk of endemic Burkitt lymphoma in children. However, the impact of Epstein-Barr virus infections on the development of immunity to P. falciparum has not been studied in depth. In this review, we examine novel findings from animal co-infection models and human immuno-epidemiologic studies to speculate on the impact of acute gammaherpesvirus co-infection on malarial disease severity. Children are often concurrently or sequentially infected with multiple pathogens, and this has implications for understanding the development of protective immunity as well as in the evaluation of vaccine efficacy.

Indexed as

Acute DiseaseAfrica South of the SaharaAnimalsBurkitt LymphomaChildCoinfectionCytokinesDisease Models, AnimalEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHumansMalaria, FalciparumT-LymphocytesCytokinesanimal modelsco-infectionepidemiologic studiesimmunity

Identifiers

PMID26121587
PMCPMC10290429
OpenAlexW1598149253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.